Intellia Therapeutics, Inc. (NTLA)
12.64
-0.40
(-3.07%)
USD |
NASDAQ |
Feb 20, 16:00
12.68
+0.04
(+0.32%)
After-Hours: 20:00
Intellia Therapeutics Market Cap : 1.464B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.800B |
| Personalis, Inc. | 735.30M |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Pacific Biosciences of California, Inc. | 486.07M |
| Twist Bioscience Corp. | 2.979B |
Market Cap Related Metrics
| PS Ratio | 23.03 |
| Price to Book Value | 1.956 |
| Price | 12.64 |
| Earnings Yield | -33.75% |